A high-penetrance intergenic variant at 9p21 confers melanoma susceptibility
Maria Teresa Landi(Cancer Institute (WIA)), Ketty Peris(Università Cattolica del Sacro Cuore), Stefania Pellegrini(Istituto Oncologico Veneto), Míriam Potrony(Hospital Clínic de Barcelona), Cristina Pellegrini(University of L'Aquila), Lorenza Pastorino(Ospedale Policlinico San Martino), Maria Chiara Scaini(Istituto Oncologico Veneto), Joshuah Yon, Siranoush Manoukian(Fondazione IRCCS Istituto Nazionale dei Tumori), Lucia Di Nardo(Università Cattolica del Sacro Cuore), Donato Calista(Ospedale “M. Bufalini” di Cesena), Chiara Menin(Istituto Oncologico Veneto), Francesco Spagnolo(Martin University), Weiyin Zhou(Leidos (United States)), William Bruno(University of Genoa), Irene Bottillo(Carlo Forlanini Hospital), R Hartman(Harvard University), Monica Rodolfo(Fondazione IRCCS Istituto Nazionale dei Tumori), Chia‐Han Lee(National Institutes of Health), Monia Di Prete(San Gallicano Hospital), Rohit Thakur(National Institutes of Health), Paula Aguilera-Peiró(Hospital Clínic de Barcelona), Tam-Anh Tran, Jessica Scales(National Institutes of Health), Kristine Jones(Leidos (United States)), Sophie Papiernik(National Institutes of Health), Linh Bui-Raborn, Haoyu Zhang, Katerina Kypreou(National and Kapodistrian University of Athens), Enrica Tanda(University of Genoa), Belynda Hicks, Timothy Myers, Irene Stefanaki(National and Kapodistrian University of Athens), Tongwu Zhang, Mai Xu, Lee Wheless(Vanderbilt University Medical Center), Paul Scheet, Jia Liu, Jacob Williams, Maria Concetta Fargnoli(San Gallicano Hospital), Carlo Cota(San Gallicano Hospital), Yao Yu(The University of Texas MD Anderson Cancer Center), Bruna Dalmasso(Azienda Ospedaliera di Perugia), Phuc Hoang, Aurélie Vogt, Chad Huff(The University of Texas MD Anderson Cancer Center), Nesreen Shahrour, Zaida García‐Casado(Fundación Instituto Valenciano de Oncología), Xiaoyu Wang, Wen Luo(Leidos (United States))
Cited by 0
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
|Annals of Oncology|2016|398
Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
|The American Journal of Human Genetics|2008|284
Genome-wide association study identifies three new melanoma susceptibility loci
|Nature Genetics|2011|250
Understanding the Molecular Genetics of Basal Cell Carcinoma
|International Journal of Molecular Sciences|2017|243